dc.contributor.author
Soll, Dominik
dc.contributor.author
Gawron, Julia
dc.contributor.author
Pletsch-Borba, Laura
dc.contributor.author
Spranger, Joachim
dc.contributor.author
Mai, Knut
dc.date.accessioned
2023-11-30T15:59:21Z
dc.date.available
2023-11-30T15:59:21Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/41667
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-41387
dc.description.abstract
Background: While short-term effects of weight loss on quality of life and metabolic aspects appear to be different in metabolically healthy (MHO) and metabolically unhealthy obese (MUO), respective long-term data is still missing. Given the high relevance of long-term changes, we aimed to address these in this post-hoc analysis of the MAINTAIN trial.
Methods: We analyzed 143 overweight/obese subjects (BMI >= 27 kg/m(2), age >= 18 years) before and after a 3-month weight loss program (>= 8% weight loss), after a 12-month period of a randomized weight maintenance intervention (n =121), and after another 6 months without intervention (n=112). Subjects were retrospectively grouped into MHO and MUO by the presence of metabolic syndrome and secondarily by estimates of insulin sensitivity (HOMA-IR and ISIclamp). Quality of life (QoL), blood pressure, lipids, HOMA-IR, and ISIclamp were assessed and evaluated using mixed model analyses.
Results: Despite similar short- and long-term weight loss, weight loss-induced improvement of HOMA-IR was more pronounced in MUO than MHO after 3 months (MHO: 2.4[95%-CI: 1.9-2.9] vs. 1.6[1.1-2.1], p= 0.004; MUO: 3.6[3.2-4.0] vs. 2.0[1.6-2.4], p < 0.001; p= 0.03 for inter-group comparison). After 21 months, the beneficial effect was no longer seen in MHO (2.0[1.5-2.6], p= 1.0), while it remained partially preserved in MUO (2.9[2.4-3.3], p= 0.002). QueryShort-term improvements of lipid parameters were similar in both groups. However, long-term improvements of HDL-cholesterol and triglycerides were only seen in MUO (44.4[41.5-47.4] vs. 49.3[46.2, 52.3] mg/dl, p < 0.001; 176.8[158.9-194.8] vs. 138.8[119.4-158.3] mg/dl, p < 0.001, respectively) but not in MHO. Weight loss-induced improvements in the QoL and particularly the physical health status were maintained in MUO until the end of the trial, while benefits disappeared over time in MHO. Group allocation by HOMA-IR and ISIclamp revealed higher benefits for MUO mainly in parameters of the glucose metabolism and QoL.
Conclusions: Our data demonstrates stronger and longer-lasting improvements of metabolism and QoL in MUO after weight loss.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Healthy obesity
en
dc.subject
Insulin sensitivity
en
dc.subject
Quality of life
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Long-term impact of the metabolic status on weight loss-induced health benefits
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
25
dcterms.bibliographicCitation.doi
10.1186/s12986-022-00660-w
dcterms.bibliographicCitation.journaltitle
Nutrition and Metabolism
dcterms.bibliographicCitation.number
1
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.volume
19
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
35346256
dcterms.isPartOf.eissn
1743-7075